Our data identify MYC as a pivotal transcriptional regulator of the ESURATAG gene set (Figure 7), aligning with previous research establishing MYC’s role in driving tumor onset and progression in gliomas (Annibali et al., 2014; Sun et al., 2024). The gene discussed is MYC; the disease is glioma.